Back to Search Start Over

Supplemental Figure 1 from Baseline Plasma Tumor Mutation Burden Predicts Response to Pembrolizumab-based Therapy in Patients with Metastatic Non–Small Cell Lung Cancer

Details

Database :
OpenAIRE
Accession number :
edsair.doi.dedup.....ab8830cf164cccd5b1739f881aa15920
Full Text :
https://doi.org/10.1158/1078-0432.22475619.v1